Zied Gaieb, as a postdoctoral research scholar at University of California San Diego, worked under the supervision of Professors Rommie E. Amaro and Michael K. Gilson. There, he focused on the structural characterization of the SARS-CoV-2 Spike protein; and pioneered state-of-the-art solutions for automating multi-target drug design and analysis. He authored more than 15 publications including his latest work on the Coronavirus that was featured in numerous prestigious media outlets including WIRED, Forbes, KBPS, Scientific American, and The New York Times. Zied was awarded his Ph.D. in Bioengineering at the University of California Riverside under Professor Dimitrios Morikis, and is currently the co-founder and Senior VP of Computation at Athae Bio Inc.
ACM Gordon Bell COVID Finalist